The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Lymphangiogenesis

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Lymphangiogenesis

 

High impact information on Lymphangiogenesis

 

Biological context of Lymphangiogenesis

 

Anatomical context of Lymphangiogenesis

 

Associations of Lymphangiogenesis with chemical compounds

 

Gene context of Lymphangiogenesis

 

Analytical, diagnostic and therapeutic context of Lymphangiogenesis

References

  1. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Skobe, M., Hawighorst, T., Jackson, D.G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., Detmar, M. Nat. Med. (2001) [Pubmed]
  2. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Mäkinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M.I., Pulkkanen, K.J., Kauppinen, R., Jackson, D.G., Kubo, H., Nishikawa, S., Ylä-Herttuala, S., Alitalo, K. Nat. Med. (2001) [Pubmed]
  3. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L.F., Detmar, M. J. Exp. Med. (2005) [Pubmed]
  4. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Byzova, T.V., Goldman, C.K., Jankau, J., Chen, J., Cabrera, G., Achen, M.G., Stacker, S.A., Carnevale, K.A., Siemionow, M., Deitcher, S.R., DiCorleto, P.E. Blood (2002) [Pubmed]
  5. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Karkkainen, M.J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T.V., Jeltsch, M., Jackson, D.G., Talikka, M., Rauvala, H., Betsholtz, C., Alitalo, K. Nat. Immunol. (2004) [Pubmed]
  6. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. Cursiefen, C., Chen, L., Borges, L.P., Jackson, D., Cao, J., Radziejewski, C., D'Amore, P.A., Dana, M.R., Wiegand, S.J., Streilein, J.W. J. Clin. Invest. (2004) [Pubmed]
  7. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. He, Y., Kozaki, K., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., Alitalo, K. J. Natl. Cancer Inst. (2002) [Pubmed]
  8. Hepatocyte growth factor promotes lymphatic vessel formation and function. Kajiya, K., Hirakawa, S., Ma, B., Drinnenberg, I., Detmar, M. EMBO J. (2005) [Pubmed]
  9. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Cho, C.H., Sung, H.K., Kim, K.T., Cheon, H.G., Oh, G.T., Hong, H.J., Yoo, O.J., Koh, G.Y. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  10. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Baldwin, M.E., Halford, M.M., Roufail, S., Williams, R.A., Hibbs, M.L., Grail, D., Kubo, H., Stacker, S.A., Achen, M.G. Mol. Cell. Biol. (2005) [Pubmed]
  11. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Su, J.L., Shih, J.Y., Yen, M.L., Jeng, Y.M., Chang, C.C., Hsieh, C.Y., Wei, L.H., Yang, P.C., Kuo, M.L. Cancer Res. (2004) [Pubmed]
  12. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Shibuya, M., Claesson-Welsh, L. Exp. Cell Res. (2006) [Pubmed]
  13. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Cursiefen, C., Cao, J., Chen, L., Liu, Y., Maruyama, K., Jackson, D., Kruse, F.E., Wiegand, S.J., Dana, M.R., Streilein, J.W. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  14. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Religa, P., Cao, R., Bjorndahl, M., Zhou, Z., Zhu, Z., Cao, Y. Blood (2005) [Pubmed]
  15. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. Vlahakis, N.E., Young, B.A., Atakilit, A., Sheppard, D. J. Biol. Chem. (2005) [Pubmed]
  16. Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro. Tille, J.C., Wang, X., Lipson, K.E., McMahon, G., Ferrara, N., Zhu, Z., Hicklin, D.J., Sleeman, J.P., Eriksson, U., Alitalo, K., Pepper, M.S. Exp. Cell Res. (2003) [Pubmed]
  17. Basic fibroblast growth factor-mediated lymphangiogenesis of lymphatic endothelial cells isolated from dog thoracic ducts: effects of heparin. Tan, Y. Jpn. J. Physiol. (1998) [Pubmed]
  18. Influence of angiostatin and thalidomide on lymphangiogenesis. Shao, X.J., Chi, X.Y. Lymphology. (2005) [Pubmed]
  19. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. Nagy, J.A., Vasile, E., Feng, D., Sundberg, C., Brown, L.F., Detmar, M.J., Lawitts, J.A., Benjamin, L., Tan, X., Manseau, E.J., Dvorak, A.M., Dvorak, H.F. J. Exp. Med. (2002) [Pubmed]
  20. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Lymboussaki, A., Olofsson, B., Eriksson, U., Alitalo, K. Circ. Res. (1999) [Pubmed]
  21. Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3. Matsumura, K., Hirashima, M., Ogawa, M., Kubo, H., Hisatsune, H., Kondo, N., Nishikawa, S., Chiba, T., Nishikawa, S. Blood (2003) [Pubmed]
  22. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Karpanen, T., Egeblad, M., Karkkainen, M.J., Kubo, H., Ylä-Herttuala, S., Jäättelä, M., Alitalo, K. Cancer Res. (2001) [Pubmed]
  23. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. Skobe, M., Brown, L.F., Tognazzi, K., Ganju, R.K., Dezube, B.J., Alitalo, K., Detmar, M. J. Invest. Dermatol. (1999) [Pubmed]
  24. Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA. Weich, H.A., Bando, H., Brokelmann, M., Baumann, P., Toi, M., Barleon, B., Alitalo, K., Sipos, B., Sleeman, J. J. Immunol. Methods (2004) [Pubmed]
  25. Control of vascular cell differentiation by homeobox transcription factors. Gorski, D.H., Walsh, K. Trends Cardiovasc. Med. (2003) [Pubmed]
 
WikiGenes - Universities